Training for better diagnosis of lung diseases using cryobiopsy
Learning Curve for the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy and the Role of Standardized Training in It
NA · China-Japan Friendship Hospital · NCT06245954
This study is testing whether special training for doctors on a lung biopsy technique can help them diagnose lung diseases more accurately.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06245954 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of standardized training methods, including simulator and in vitro lung training, for physicians performing transbronchial lung cryobiopsy (TBLC). It aims to assess the learning curve of these physicians and determine how structured training can improve diagnostic accuracy for interstitial lung disease (ILD). The study is designed as a prospective randomized controlled trial to ensure robust results. Participants will be monitored for their performance in TBLC after undergoing different training approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with suspected interstitial lung disease and specific pulmonary function criteria.
Not a fit: Patients with severe coagulopathy or those who refuse to participate in the study may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic capabilities of physicians, leading to more accurate and timely diagnoses of interstitial lung disease.
How similar studies have performed: While the specific approach of standardized training in TBLC is novel, similar training methodologies in other medical procedures have shown promising results in improving physician performance.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * suspected ILD. * ≤3 months since HRCT * Forced vital capacity (FVC) ≥50% of predicted value * Diffused lung carbon monoxide (DLCO) ≥35% predicted value * Echocardiography ≤ 12 months * Estimated pulmonary artery systolic pressure ≤40 mmHg * Body mass index (BMI) ≤35 kg/m2 * Patient consent for experimentation Exclusion Criteria: * Patients with platelet counts less than 50 × 109/L or prothrombin time international normalized ratio (INR) higher than 1.5 * Patients refused to participate in the experiment
Where this trial is running
Beijing, Beijing Municipality
- China-Japan Friendship Hospital — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Mingming Deng, MD
- Email: isdeng1017@163.com
- Phone: 86 18801336854
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Transbronchial Lung Cryobiopsy, transbronchial lung cryobiopsy, standardized training, learning curve, bronchoscopist